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Abstract. We have generated a series of plectin dele- 
tion and mutagenized cDNA constructs to dissect the 
functional sequences that mediate plectin's interaction 
with intermediate filament (IF) networks, and scored 
their ability to coalign or disrupt intermediate filaments 
when ectopically expressed in rat kangaroo PtK2 cells. 
We show that a stretch of ~50 amino acid residues 
within plectin's carboxy-terminal repeat 5 domain 
serves as a unique binding site for both vimentin and 
cytokeratin IF networks of PtK2 cells. Part of the IF- 
binding domain was found to constitute a functional 
nuclear localization signal (NLS) motif, as demon- 
strated by nuclear import of cytoplasmic proteins 
linked to this sequence. Site directed mutagenesis re- 
vealed a specific cluster of four basic amino acid resi- 
dues (arg4277-arg  428°) residing within the NLS sequence 
motif to be essential for IF binding. When mutant pro- 
teins corresponding to those expressed in PtK2 cells 
were expressed in bacteria and purified proteins sub- 
jected to a sensitive quantitative overlay binding assay 
using Eu3+-labeled vimentin, the relative binding ca- 
pacities of mutant proteins measured were fully consis- 
tent with the mutant's phenotypes observed in living 
cells. Using recombinant proteins we also show by neg- 
ative staining and rotary shadowing electron micros- 
copy that in vitro assembled vimentin intermediate fila- 
ments become packed into dense aggregates upon 
incubation with plectin repeat 5 domain, in contrast to 
repeat 4 domain or a mutated repeat 5 domain. 
T 
HE intermediate filament (IF)Lbinding protein plec- 
tin (Wiche et al.,  1982) is abundantly expressed in 
many different tissues and cell types. It shows par- 
tial codistribution with different types of IFs and it is con- 
spicuously arranged at plasma membrane attachment sites 
of  IFs  and  microfilaments,  including  hemidesmosomes 
(Wiche et al., 1984), Z-line structures and dense plaques of 
striated and smooth muscle, and intercalated discs of car- 
diac muscle and focal contacts (Wiche et al., 1983; Zernig 
and  Wiche,  1985; Seifert  et  al.,  1992).  Furthermore,  in 
many tissues, among them kidney (Yaoita et al.,  1996) 
and brain (Errante et al., 1994), plectin is prominently ex- 
pressed in cells forming tissue layers at the interface of tis- 
sue and fluid filled cavities. These observations suggest a 
role of plectin in mechanically strengthening cells against 
pulling or shearing forces occurring along cell surfaces and 
at intracellular attachment sites of cytoskeletal filaments. 
Consistent with this idea is a recent report by Gache et al. 
(1996)  showing that a  defect in plectin expression is ob- 
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served in epidermolysis bullosa simplex (EBS)-MD, a skin 
blistering disease associated with muscular dystrophy. 
As shown biochemically, apart from cytoplasmic as well 
as  nuclear  IF  subunit  proteins,  such  as  vimentin,  glial 
fibrillary acidic  protein,  certain  cytokeratins, neurofila- 
ment proteins, and lamin B, plectin specifically interacts 
with  the  subplasma  membrane  protein  fodrin  and  its 
erythroid counterpart ct-spectrin, and it binds to high tool 
wt  microtubule-associated  proteins  (Herrmann  and 
Wiche, 1987; Foisner et al., 1988; 1991). Plectin is a promi- 
nent phosphoprotein and has been demonstrated to be an 
in vivo target for different types of kinases including Ca2+/ 
calmodulin-dependent kinases, protein kinases A  and C, 
and  mitotic cyclin-dependent p34  cdc2 kinase  (Herrmann 
and Wiche, 1983, 1987; Foisner et al., 1991, 1996). Interest- 
ingly, in vitro assays showed that plectin's capacity to bind 
to vimentin and lamin B were differentially influenced by 
kinase A  and kinase  C  phosphorylation (Foisner et  al., 
1991), and that phosphorylation of the molecule by p34  ~dc2 
kinase during mitosis at a unique site correlated with its in- 
creased  solubility and  dissociation from cytoplasmic vi- 
mentin filament networks in  CHO  cells  (Foisner et  al., 
1996; Malecz et al., 1996). Thus, phosphorylation involving 
distinct kinases probably is a major mechanism regulating 
the various molecular interactions of plectin that are  of 
importance for its proposed function as a versatile cross- 
linking element of cytoarchitecture. 
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tides known. Ultrastructural studies (Foisner and Wiche, 
1987), as well as secondary structure predictions based on 
the deduced amino acid sequences of both rat and human 
cDNAs and genomic clones (Wiche et al., 1991; Liu et al., 
1996),  revealed  that  the  molecule  is  dumbbell-shaped, 
comprising a  long central c~-helical coiled coil rod struc- 
ture  flanked  by  two  globular  domains.  The  dominant 
structural  feature  of  the  carboxy-terminal  domain,  six 
highly homologous repeats exhibiting in their core a tan- 
demly repeated l%amino acid sequence motif, occur in 
lesser numbers also in other IF-associated proteins, such 
as the hemidesmosome-associated bullous pemphigoid an- 
tigen(BPA)-I  (Sawamura  et  al.,  1991)  and  desmoplakin 
(Green et al., 1990), a constituent of desmosomes. 
The cloning and sequencing of plectin  cDNA opened 
new avenues to study questions related to the domain or- 
ganization of the molecule and to a  precise mapping of 
functional epitopes by expression of mutant forms of plec- 
tin in cell lines  transiently  transfected with  cDNA  con- 
structs. Our initial studies, carried out with a rat kangaroo 
(PtK2) and a monkey (COS) cell line, both of which are of 
simple epithelial origin and contain dense networks of vi- 
mentin filaments in addition to cytokeratin filaments, indi- 
cated that plectin's carboxy-terminal globular domain, in 
particular  sequences  within  the  last  two  thirds  (~1,500 
amino  acid  residues)  of the carboxy terminus,  played a 
role in IF association (Wiche et al., 1993).  NH2-terminal 
globular  or  central  rod  domains,  on  the  other  hand, 
seemed to be dispensable for IF association. The study re- 
ported here was undertaken to localize and characterize 
plectin's  carboxy-terminal  IF-binding  site(s)  more  pre- 
cisely. In  addition  to studying the  phenotype of plectin 
mutant proteins expressed in PtK2 cells in vivo, we per- 
formed quantitative  and  ultrastructural  in vitro binding 
assays,  using  recombinant mutant  proteins expressed in 
bacteria. We found that a sequence of ~50 amino acid res- 
idues within the fifth carboxy-terminal repeat domain, re- 
siding downstream of the tandem repeat core domain, is 
indispensable for binding to IFs. An essential part of this 
sequence has structural and functional characteristics typi- 
cal of nuclear localization signals (NLS), Furthermore, we 
show that  the  in  vitro decoration of vimentin filaments 
with the repeat 5 domain of plectin leads to filament net- 
work formation. 
Materials and Methods 
Construction of  Expression Plasmids and Mutagenesis 
Rat plectin cDNA fragments were amplified by PCR from previously de- 
fined  plectin  constructs  using EcoRI-tailed  primers,  and  cloned  into 
pAD29, a modified version of pGW15 (Wiche at at., 1993),  enabling the 
expression of carboxy-terminal c-myc-tagged proteins. Internal deletions 
and targeted mutagenesis of amino acid residues were generated by SOE- 
PCR (Horton et al., 1989)~ To prepare pAD29, sequences encoding the 
spacer  amino acids  and  P  epitope  tag of pGW15  were  excised as  an 
EcoRI-BamHI fragment and replaced by the c-myc tag. One pair of syn- 
thetic oligonucleotides encoding the c-myc epitope, MEQKLISEEDLN, 
followed by  a  stop codon included  within a  XbaI  recognition site and 
flanked  by  EcoR1  and BamHl overhangs were  ligated  into pGW15, 
previously digested with EcoRI and BamHI. The sequence of the sense 
oligonucleotides was AATFCATGGAGCAAAAGCTCATT~CTGAA- 
GAGGACTTGAATGTCTAGAGCG. In two cases (pBN16 and pBN18), 
cDNA constructs subcloned into pAD29 were used directly for transfec- 
tion into mammalian cells, in all others, HindllI-XbaI fragments excised 
from pAD29 constructs were  subcloned into the eukaryotic expression 
vector pRc/CMV (Invitrogen, San Diego, CA). For bacterial expression, 
EcoRl  fragments were  subcloned into  pBN120,  a  pET-15b  (Novagen, 
Madison, WI) derivative in which the endogenous BgllI and EcoRI sites 
were destroyed and a linker, containing an EcoRl cloning site and an in- 
frame stop codon, ligated between the NdeI and BamHI sites. Plasmid 
pBN88 encoding chicken pyruvate kinase (PK)  (from leu 17 to met 52) 
fused to a c-myc tag at its 5' end and to plectin's NLS sequence at its 3' 
end was constructed by PCR amplification of the cDNA corresponding to 
plectin's 19-amino acid-long NLS domain, and subsequent in-flame liga- 
tion of the amplified sequences into plasmid BSmycPKOstp (a kind gift of 
Dr. M. Schmidt-Zachmann, DKFZ, Heidelberg, FRG) downstream of the 
PK coding sequence, as a  Hindlll-Clal  fragment. An XbaI-Apal frag- 
ment containing the entire  coding sequence for the fusion protein  was 
then subcloned into a modified pRc/CMV expression vector, in which the 
sequences between the HindlII and Apal in the vector cloning site were 
replaced by a  linker containing Xbal  and Clal sites followed by a stop 
codon, without reconstitution of the HindlII restriction site. Control plas- 
mid pBN86 (expressing myc-tagged PK without NLS) was obtained by 
subcloning an XbaI-Clal  fragment of plasmid BSmycPKOstp into  this 
modified version of pRc/CMV. Plasmid constructs were verified by DNA 
sequencing, 
Cell Culture, DNA Transfection,  and 
Immunofluorescence Microscopy 
Rat kangaroo PtK2 (CCL 56, Amer. Type Culture Collection, Rockville, 
MD) and transformed mouse epidermal keratinocytes Pam 212 (Yuspa 
et al., 1980) were grown attached to glass slides in plastic dishes in DMEM 
supplemented with 2 mM L-glutamine, 50 U/ml penicillin, 50 p.g/ml strep- 
tomycin, and 10% of heat-inactivated FCS, at 37°C and 5% CO2. Subcon- 
fluent cells were transiently transfected with 30 p,g plasmid DNA/10-cm 
plate using the calcium phosphate precipitation method (Graham and van 
der Erb, 1973). After fixation in methanol at -20°C, 40-60 h posttransfec- 
tion cells were processed for immunofluorescence microscopy as previ- 
ously described (Wiche et al., 1993). The following immunoreagents were 
used: affinity-purified goat anti-mouse vimentin (Giese and Traub, 1986: 
kindly provided by Dr. Peter Traub, MPI f. Zellbiologie, Ladenburg, Ger- 
many), guinea pig anti-mouse liver cytokeratin (Denk et al., 1981; kindly 
provided by Dr. H. Denk), and anti-myc mAh 1-9E10.2 (Amer. Type Culture 
Collection), as primary antibodies; and Texas red-conjugated AffiniPure 
donkey  anti-mouse  IgG  (H+L);  fluorescein  (DTAF)-conjugated  Af- 
finiPure donkey anti-goat IgG (H + L); AMCA  TM fluorophore-conjugated 
AffiniPure donkey anti-guinea pig IgG (H+L)  all with minimal species 
crossreactivity (Accurate, Westbury, NY), as secondary antibodies. Speci- 
mens were  viewed in a  Zeiss Axiophot fluorescence microscope (Carl 
Zeiss, Oberkochen, Germany) and photographs were taken using Ilford 
ASA 400 black and white film, 
Expression of  Plectin Mutants in Bacteria 
His-tagged recombinant proteins encoded by pBN120 constructs were 
expressed in E.coli BL21(DE3) and purified from inclusion bodies by sol- 
ubilization in 500 mM NaCl, 20 mM Tris, pH 7.9 (binding buffer) contain- 
ing 5 mM imidazole and 6 M  urea followed by affinity binding to His- 
Bind  ® metal chelation resin according to the manufacturer's (Novagen) 
protocol. Proteins bound were eluted from affinity columns with a gradi- 
ent  of 60  mM-1 M  imidazole  in binding buffer, and  stored  frozen  at 
-20°C at protein concentrations of 0.5-1 mg/mL The correct size of ex- 
pressed proteins was verified by SDS 10% PAGE (see Fig. 5 A). 
Preparation of Vimentin for In Vitro Assays 
Vimentin was purified from rat glioma C6 cells using a protocol described 
in detail by Foisner et al. (1988).  Stocks of vimentin in 7  M  urea were 
stored frozen (-80°C) at a concentration of 1-2 mg/ml. For in vitro over- 
lay binding assays, 100 p~l of vimentin stock were dialyzed against 50 mM 
NaHCO  3, pH 8,5,  and then labeled with Eu  3+ using 10/.d Eu3+-labeling 
reagent following the instruction of the manufacturer (Wallac, Turku, Fin- 
land). 
For electron microscopy, vimentin stocks were incubated with  I  mM 
DTT for 30 min on ice and subsequently spun at 200,000 g for 10 min at 
4°C. Soluble fractions were desalted into 5 mM Tris, pH 8.5, 1 mM DTT, 1 
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sala, Sweden), and again spun at 200,000 g for 30 min. To assemble IFs in 
vitro, soluble fractions were diluted to a  concentration of 150  ixg/ml of 
protein, 1A0th volume of 1.6 M  NaCI, 200 mM Tris, pH 7.0, was added, 
and  mixtures incubated  for  1  h  at  37°C.  Preassembled filaments, were 
mixed 1:1 (vol/vol) with solutions containing 150 p,g/ml recombinant plec- 
tin mutant proteins in the same buffer, or with buffer alone, and subjected 
to a 1-h incubation at 37°C before processing for electron microscopy. 
Protein concentrations were determined according to Bradford (1976). 
Overlay Binding Assay 
Microtiter plates were coated with 100 ~l of rat plectin mutant proteins 
expressed in bacteria (100 nM in 100 mM sodium borate, pH 9.2) over- 
night at 4°C. Blocking was carried out with 4% BSA in PBS for 1 h and 
then binding with  100 nM Eu3+-labeled vimentin in  100  pJ  of overlay 
buffer (PBS, pH 7.5, containing 1 mM EGTA, 2 mM MgCl  2, 1 mM DTT, 
and 0.1% Tween 20) for 90 min at room temperature. After washing ex- 
tensively, bound vimentin was determined by releasing complexed Eu  3+ 
with Enhancement Solution and measuring the fluorescence with a  Del- 
phia time-resolved fluorometer (Wallac). The fluorescence values were 
converted to concentrations by comparison with a Eu  3+ standard. 
Cloning, PCR, and DNA Sequencing 
Restriction enzymes and T4 DNA ligase used for cloning were purchased 
from Promega (Madison, WI); PCR was done with thermostable DNA 
polymerases Dynazyme (Finnzymes Oy, Espoo, Finland) or Taq (GIBCO 
BRL,  Gaithersburg,  MD)  on  a  DNA  Thermal  Cycler  (Perkin  Elmer 
Corp., Norwalk, CT) using standard conditions (Saiki et al., 1988).  Dou- 
ble-stranded plasmid DNA was sequenced using a Sequenase Version 2.0 
sequencing kit (USB, Cleveland, OH). 
Electron Microscopy 
For uranyl acetate staining of specimens, drops (7 Ixl) of mixtures contain- 
ing vimentin filaments polymerized in vitro  and decorated  with plectin 
mutant proteins (see above) were deposited onto Formvar/carbon-coated 
and glow-discharged 400 mesh Cu-grids for 30 s, and then stained with 
eight drops of 1% uranyl acetate for 20 s. For rotary shadowing, samples 
(50 ixl) mixed with glycerol (1:1) were sprayed onto freshly cleaved mica 
and processed for electron microscopy essentially as described by Tyler 
and Branton (1980). The shadowing with platinum (thickness of film: 0.74 
nm) occurred at an angle of 7  °, shadowing with carbon  (10 nm) at 90  °. 
Specimens were visualized in a JEOL 1210 electron microscope operated 
at 80 kV. 
Results 
The Fifth Carboxy, Terminal Repeat Domain of Plectin 
Harbors a Unique Vimentin-binding Site 
Previous transfection  experiments  using mutant forms of 
plectin indicated a role of plectin's carboxy-terminal glob- 
ular domain in IF association (Wiche et al., 1993). To pin- 
point  the  vimentin  interaction  site  within  this  domain 
cDNA constructs encoding various parts of it (Fig. 1) were 
transiently expressed in PtK2 cells with a short immunore- 
active  sequence  derived  from  the  human  c-myc  protein 
fused  to their  3'  ends.  A  cDNA construct  (pBN72;  see 
Fig.  1),  corresponding  to roughly two  thirds  of the  car- 
boxy-terminal  globular  domain  and  encoding  a  mutant 
protein still capable of association with IFs, served as the 
basic template for all other mutants to be generated. The 
new constructs were scored positive  for IF association  if 
they showed  any of the  phenotypes  characterized  previ- 
ously, including the alignment with filaments, or their bun- 
dling and collapse  (Wiche et al.,  1993).  When a  series  of 
truncated  versions  of pBN72  (Fig.  1),  lacking  sequences 
from either its 3' or 5' ends, or from both ends, were ex- 
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Figure 1.  Overview of ectopically expressed plectin mutant pro- 
teins and summary of observed phenotypes. Schematic drawing 
on top represents  the major molecular domains of plectin.  GN 
and GC, NH  2- and COOH-terminal globular domains, respec- 
tively; numbered ellipsoids,  repeat domains 1-6. Sequence below 
represents  vimentin-binding domain with  positions  of relevant 
amino acid residues indicated. (The amino acid sequence extends 
the published rat sequence (Wiche et al., 1991) at its amino termi- 
nus by 547 residues;  the complete cDNA nucleotide sequence is 
available from the EMBL data library under accession number 
X59601.) Note that not all the amino acids shown (position 4281- 
4316) may be essential for vimentin binding (see text).  Mutated 
amino acid residues are in bold. Consensus sequences of bipartite 
NLS and SV40 T antigen-like NLS motifs are indicated by brack- 
ets.  pBN123,  pBN132-135,  and pBN141-148  represent  bacteria/ 
expression  vector constructs,  Internal  deletions  in  pBN73/145 
and pBN85/146 are indicated. +-, positive or negative phenotypes 
observed in vivo after transient transfection of PtK2 cells. In vitro 
binding data (right hand column) are based on assays  shown in 
Fig. 5 B, taking binding activity of repeat 5 as 100%. rid, not de- 
termined. *, pBN134, -147, and -148 were like pBN83, -82, and 
-84, respectively, except for starting at the 5' end of repeat 5. 
amined, positive phenotypes were observed only with mu- 
tant  proteins  containing  repeat  5  or  certain  parts  of it 
(Figs. 2, A  and B; 3, B  and C; 4 A; and 8; see Fig.  1 for a 
survey). Two partially overlapping constructs, pBN18 (Fig. 
2 A) and pBN56 (Fig. 2 B) showed a positive phenotype, 
in contrast to pBN58 (Fig. 2 C), a 5' truncated version of 
pBN56.  Note, however, that the mutant  protein  encoded 
by pBN18, apart  from being associated  with distinct  fila- 
ments,  showed  additional  more  diffuse  diStribution  over 
Nikolic et al. Analysis of Plectin-Vimentin Binding Site  1457 Figure 2.  Expression of 3' and 5' truncated versions of plectin reveal vimentin-binding  site in repeat 5. Double immunofluorescence  mi- 
croscopy  is shown, primary antibodies are indicated. Expression plasmids: pBN18  (A, A'), pBN56  (B, B'), and pBN58 (C, C'). Note 
slightly diffuse (nonfilamentous)  distribution in addition to IF-association of mutant protein in A', prominent filament association in B', 
and diffuse cytoplasmic distribution in C'. Bar, 15 ~m. 
The Journal  of Cell Biology, Volume 134, 1996  1458 Figure 3.  Targeted mutagenesis of NLS sequence domain within  vimentin-binding site.  Double immunofluorescence microscopy is 
shown, primary antibodies are indicated. Expression plasmids: pBN83 (A, A'), pBN82 (B, B'), and pBN84 (C, C'). Note nonfilamentous 
cytoplasmic staining in A', filament  association  accompanied by diffuse cytoplasmic staining in B', and exclusive filament association in C'. 
Bar, 15 ixm. 
Nikolic et al. Analysis of Plectin-Vimentin Binding Site  1459 Figure  4.  The NLS sequence domain within 
plectin's vimentin-binding site mediates nu- 
clear  import.  Double  immunofluorescence 
staining  (A,  A')  and  immunostaining  com- 
bined with nuclear (HOECHST dye) staining 
(B,  B'-D,  D')  of PtK2 cells are shown. Pri- 
mary antibodies are indicated. Double panels 
show transfectants obtained using the follow- 
ing plasmids: A, A', pBN16 (see Fig. 1); B, B', 
pBN85  (see Fig.  1);  C,  C',  pBN86  (control 
myc-tagged  pyruvate  kinase);  and  D,  D', 
pBN88 (myc-tagged pyruvate kinase fused to 
plectin's  19-amino  acid  NLS  sequence  do- 
main). Bar, 15 ~m. 
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Such  a  phenotype  would  have  been  consistent  with  a 
weaker binding of this mutant to the filamentous network, 
a  notion supported by in vitro binding data  (see below). 
Thus, apparently a  sequence of ,-,~50 amino acid residues 
within the carboxy-terminal one third of the repeat 5 do- 
main (positions 4262-4316;  see scheme on top of Fig.  1), 
was indispensable  for filament association.  As two other 
mutant  proteins  spanning  over this  domain  but  carrying 
deletions  in  the  amino- and carboxy-terminal halfs of it, 
pBN73 (data not shown) and pBN85 (Fig. 4 B), displayed 
negative phenotypes we  concluded  that  most  of this  se- 
quence, if not all of it, was required for colocalization with 
IFs in cells. 
A Basic Cluster of  Amino Acid Residues Located 
within a Functionally Intact NLS Sequence Motif Is 
Essential  for Vimentin Binding 
The  NH2-terminal  part  of the  ~50-amino  acid  residue- 
long sequence required for filament association displayed 
structural characteristics typical of bipartite NLS sequence 
motifs, having two clusters of basic amino acids (residues 
4262-4266; and 4277-4280; see Fig. 1) separated by a linker 
of 10 residues (Robbins et al., 1991). In addition, parts of 
this sequence, such as residues 4265-4269  (Fig.  1), quali- 
fied  as typical SV40 T  antigen-like NLS  (Chelsky et  al., 
1989).  The sequence connecting the  basic clusters within 
this NLS motif contained one threonine and four serines, 
which could be targets for O-linked glycosylation and/or 
phosphorylation. In fact, several consensus sequence mo- 
tifs  for protein  kinases,  including  kinases  A  and  C,  and 
cGMP-dependent  kinase  can  be  found  within  this  se- 
quence. To examine which structural elements of this se- 
quence  domain  were  essential  for  IF  binding,  several 
amino acid residues were alternatively mutated en bloc by 
site directed mutagenesis. Substitution of the basic cluster 
formed by arg4277-1ys-arg-arg  428° (pBN83) by neutral amino 
acid residues led to a completely negative phenotype (Fig. 
3  A),  suggesting  that  this  highly  positively  charged  se- 
quence was indispensable for IF binding. In contrast, neu- 
tralization of four more upstream SV40 T  antigen-like ba- 
sic residues by asparagine and alanine (pBN84) hardly had 
any detectable phenotypic effects (Fig. 3 C). Exchange of 
the  threonine  and four serines for valine and  alanines in 
the segment connecting the two basic clusters, generated a 
mutant protein (pBN82) with a mixed phenotype, showing 
diffuse cytoplasmic distribution in addition to filament as- 
sociation (Fig. 3 B). 
Although the NLS sequence domain of plectin's vimen- 
tin-binding  region  was  insufficient  without  its  carboxy- 
terminal flanking sequence to form a functional vimentin- 
binding domain, its NLS function seemed to be intact, as 
indicated by the exclusively nuclear localization of pBN85- 
encoded mutant protein, which contained the NLS domain 
but lacked its carboxy-terminal flanking sequence (Fig. 4 B). 
A  similar  mutant  protein  lacking  the  NLS  domain,  but 
containing its carboxy-terminal flanking sequence (pBN73; 
see Fig. 1) did not show this phenotype (data not shown). 
Moreover, when the 19-amino acid residue motif compris- 
ing plectin's bipartite NLS structure was linked by genetic 
engineering to pyruvate kinase, a typical cytoplasmic pro- 
Figure 5.  SDS-PAGE (A) and binding to Eu3+-labeled vimentin 
(B) of plectin mutant proteins expressed in bacteria.  (A) Plectin 
mutants expressed in bacteria were purified  as described  in the 
text. Purified  proteins were analyzed  by SDS 10% PAGE. Gels 
were  then  stained  with  Coomassie blue.  (B) Microtiter plates 
were coated with purified mutant proteins at equivalent  concen- 
trations (100 nM) and binding of 100 nM Eu3+-vimentin carried 
out as described. Data are presented as the mean -+ SD of tripli- 
cate determinations.  The experiment is typical of three. 
tein, a  myc-tagged version of the enzyme was found pre- 
dominantly within the nuclear compartment, after ectopic 
expression in PtK2 cells (Fig. 4 D). In contrast, myc-tagged 
pyruvate  kinase  without  the  plectin  NLS  sequence  re- 
tained its cytoplasmic localization (Fig. 4 C). 
Mutant Proteins Expressed in Bacteria Display 
Binding Properties Similar to Those Expressed in 
Mammalian Cells 
In vitro binding  experiments were  perfomed with corre- 
sponding plectin mutant proteins expressed in bacteria as 
histidine-tagged  versions to  enable their  purification  via 
affinity chromatography (Fig. 5 A). In a first series of ex- 
periments purified mutant proteins were coated onto mi- 
crotiter  plates,  overlaid with Eu3+-labeled  vimentin,  and 
bound vimentin quantitatively determined after release of 
complexed Eu  3+ and detection by time-resolved fluorome- 
Nikolic et al. Analysis of Plectin-Vimentin Binding Site  1461 Figure 6.  Electron microscopy of uranyl acetate-stained  vimentin IFs decorated with plectin mutant proteins expressed in bacteria. IFs 
were reconstituted from purified C6 cell vimentin stocks and incubated with affinity-purified recombinant mutant proteins as described 
in the text. Negatively stained  specimens of the following mixtures are shown: A, IFs alone  (control);  B, IFs and plectin repeat 5 
(pBN132); C, IFs and plectin repeat 4 (pBN135); and D, IFs and mutagenized plectin repeat 5 (pBN 134). Note loose tangles of fila- 
ments visualized in A, C, and D, but dense filamentous aggregates in B. Bar, 300 nm. 
try (Soini and L6vgren, 1987).  In agreement with the re- 
sults  obtained by cDNA transfection into cultured cells, 
strong binding was observed only with those mutant pro- 
teins which contained a fully intact vimentin-binding do- 
main  comprising the  NLS  sequence  domain  in  repeat 5 
and  its  carboxy-terminal  flanking  structure  (Fig.  5  B). 
Scatchard analysis of binding data obtained with pBN132- 
and  pBN123-encoded mutant proteins, corresponding to 
the entire repeat 5  domain and  its amino-terminal trun- 
cated version, respectively, revealed dissociation constants 
in the range of Kd =  0.5-0.9 ×  10  -7 M, similar to purified 
native plectin (data not shown). On a  scale in which the 
binding  efficiency of  the  polypeptide  corresponding  to 
wild-type  repeat  5  (pBN132)  was  arbitrarily  taken  as 
100%  (Fig.  1,  last  column),  only  two  mutant  proteins 
(pBN143  and  pBN148)  showed  stronger  binding  (108% 
and 124%, respectively) maybe due to better accessibility 
of their vimentin-binding site. Repeat 4  and repeat 6 in- 
cluding plectin's tail showed no binding. In fact, since the 
mutant  protein  representing  repeats  4  and  5  combined 
(pBN141)  exhibited  significantly reduced  binding  to  vi- 
mentin  (61%)  compared  to  repeat  5  protein  alone,  it 
seemed that the repeat 4 domain exerted an inhibitory ef- 
fect. However, alternative explanations, including the pos- 
sibility that repeat 5 being not in its usual protein sequence 
context, in particular without the preceding repeat 4  se- 
quence, may have an artificially increased affinity for vi- 
mentin, cannot be ruled out. The carboxy-terminal trun- 
cated version (pBN142)  of the mutant  protein encoded 
by pBN141, which displayed a weak but still positive phe- 
notype  upon  expression  in  cultured  cells  (pBNt8;  see 
Fig. 2 A), showed also rather little binding in vitro. Very 
little insignificant binding was observed with all other mu- 
tant proteins displaying negative phenotypes in transfec- 
tion  experiments, such  as  the  deletion mutants  pBN145 
and  pBN146,  the  amino-terminal  truncated  version  of 
pBN143, pBN144, and mutant pBN134 carrying mutations 
in the essential basic amino acid residue cluster within the 
NLS sequence motif. Mutant pBN147 in which the cluster 
of hydroxy-amino acid  residues  had  been  mutagenized, 
showed only moderate binding activity (19%) compared 
to wild-type repeat 5 (pBN132). Again, this was consistent 
The Journal of Cell Biology, Volume  134, 1996  1462 Figure 7.  Plectin mutant protein-vimentin IF complexes visualized by rotary shadowing electron microscopy. Vimentin  IFs were preas- 
sembled in vitro, incubated with or without purified recombinant plectin mutant proteins, and processed for rotary shadowing electron 
microscopy as described  in the text. A, IFs alone; B, IFs and plectin repeat 4 (pBN135); C, plectin repeat 4 alone; D, plectin repeat 5 
alone (pBN132); and E-G, IFs and plectin repeat 5. Note large filament-associated  protein aggregates in E-G, not observed in the ab- 
sence of filaments (D). Bar, 100 nm. 
with our results obtained by cDNA transfection into cul- 
tured cells, considering that the corresponding mutant ex- 
pressed in  PtK2  cells in  addition  to filament association 
showed  a  somewhat  diffuse  distribution  throughout  the 
cytoplasm (Fig. 3 B). Thus, in general the in vitro binding 
data were in full agreement with the immunolocalization 
of mutant proteins expressed in cultured cells. 
Decoration of Vimentin Filaments with Plectin Repeat 
5 Domain Leads to Network Formation In Vitro 
To assess effects on ultrastructure, filaments assembled in 
vitro from purified rat glioma C6 cell vimentin were incu- 
bated with selected plectin mutant proteins and examined 
by electron microscopy. After staining with uranyl acetate, 
filaments assembled from vimentin alone were  observed 
predominantly  in  the  form  of  loose  filamentous  mesh- 
works (Fig. 6 A), whereas filaments incubated at a roughly 
equimolar ratio with plectin repeat 5 formed dense aggre- 
gates. In general these  aggregates were  too dense to en- 
able resolution of substructures,  except for areas at their 
periphery, where filaments were spread more evenly upon 
the  grid.  In  such  areas  the  filaments were  heavily deco- 
rated with globular structures of various sizes, presumably 
consisting of clustered repeat 5 protein domains (Fig. 6 B). 
These structures were associated predominantly with junc- 
tional sites of the filament network, but occasionally they 
were  also observed at the  ends  of single  individual  fila- 
ments.  Notably,  some  of  the  filaments  appeared  to  be 
shorter, compared to those visualized in the control sam- 
ple  without  mutant  protein  (compare Fig.  6,  A  and  B). 
Globular  structures  not  associated  with  filaments  were 
rarely observed.  No  distinct  structures  were  observed in 
negatively  stained  samples  containing  repeat  5  protein 
without IFs (data not shown).  Statistics of several micro- 
graphs indicated that of the ~400 filament-bound protein 
complexes evaluated, 91% appeared to be junctional, i.e., 
they were associated with more than a  single continuous 
filament, 2.5% were situated at the ends of single filaments, 
and 6.5 % appeared to be laterally associated with filaments. 
When similar filament preparations were incubated with 
recombinant plectin repeat 4 domain, lacking a vimentin- 
binding  site  (Fig.  6  C),  the  ultrastructural  appearance of 
filament  networks  closely resembled  that  of the  control 
sample  (compare Fig.  6  C  with  6  A).  Finally,  filaments 
were  incubated with the  basic cluster-defective pBN134- 
encoded mutant protein exhibiting only very low vimen- 
tin-binding activity in solid phase binding assays (Fig. 5 B). 
In this case the vimentin filament network, although deco- 
rated with numerous globular aggregates, appeared much 
less dense and more spread out (Fig. 6 D) than networks 
decorated  with wild-type repeat 5  domain  (Fig.  6  B).  In 
addition, a relatively high background of globular material 
not associated with filaments was noticeable. 
Nikolic et al. Analysis of  Plectin-Vimentin Binding Site  1463 Figure 8.  Association of plectin repeat 5 domain with cytokeratin IFs in PtK2 (A, A', A" and B, B', B") and Pam 212 cells (C, C', C") 
demonstrated by triple immunofluorescence microscopy. Primary antibodies used are indicated. Plasmid pBN36 was used for transfec- 
tion. Note codistribution of mutant protein with collapsed vimentin IFs in both A' and B', but additional association with extended cy- 
tokeratin networks only in B'. No staining of Pam 212 cells was observed with antibodies to vimentin (C). Bar, 15 ~m. 
Additional  structural  detail  was revealed  when  similar 
specimens  were  visualized  after  rotary  shadowing  with 
heavy metals  (Tyler  and  Branton,  1980).  In this  case,  in 
samples of both repeat 4 alone (Fig. 7 C) and 5 alone (Fig. 
7  D),  we  observed  particles  of fairly  homogenous  sizes 
with diameters between ,--~5 and ~10 nm, Although hardly 
any such particles were detected in preparations of in vitro 
assembled filaments that were processed in the absence of 
recombinant plectin mutant proteins (Fig. 7 A), they were 
clearly seen spread over the entire grid in preparations of 
filaments incubated with either plectin repeat 4 or 5. How- 
ever, in contrast to plectin repeat 4 proteins, which, as ex- 
pected, showed no preferential  association with filaments 
(Fig. 7 B), in the case of repeat 5 proteins large filament- 
associated  protein  aggregates  were  observed  apart  from 
the  unbound  smaller  particles  (Fig.  7,  E-G).  Similar  to 
uranyl acetate-stained  specimens, the aggregated proteins 
were  predominantly  found  at junctional  sites  of the  fila- 
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ends of relatively short filaments (Fig. 7 G), generating cap- 
like structures. It is likely that capped rather than continu- 
ous filaments constituted at least part of some junctional 
complexes, considering the often uneven number of pro- 
truding filaments (for example Fig. 7 F). Since large globu- 
lar structures resembling those observed at filament junc- 
tions were not detected in the control sample containing 
repeat 5 alone (Fig. 7 D), it is likely that they formed only 
upon binding of repeat 5 to filaments. This may occur due 
to the clustering of free-binding sites for plectin in certain 
areas of the filament, such as at their ends, or cooperative 
interactions  between  bound  repeat  5  domains,  or  both. 
Studies  to distinguish  between these  and  other possible 
mechanisms have been initiated. 
EctopicaUy Expressed Plectin Repeat 5 Domain Binds 
to Both Vimentin and Cytokeratin Filaments 
To investigate whether the IF-binding site within repeat 5 
was  vimentin-specific  the  effects  of  its  overexpression 
(pBN36) on both the vimentin and the cytokeratin IF net- 
works were studied in PtK2 cells using triple fluorescence 
microscopy.  In  transiently  transfected  cells  expressing 
comparatively low levels of the mutant protein, codistribu- 
tion with vimentin but not cytokeratin IFs was observed; 
these included cells in which the vimentin filament system 
had collapsed into perinuclear aggregates, while the cyto- 
keratin filament system was  still intact (Fig. 8 A).  How- 
ever, in cells with high level expression (as judged by fluo- 
rescence intensities) the mutant protein was found associated 
with both collapsed vimentin filaments and an intact (Fig. 
8 B), or similarly collapsed, cytoplasmic cytokeratin net- 
work (data  not shown). These observations were consis- 
tent with the notion that repeat 5 in fact contained binding 
sites for both vimentin and cytokeratin IFs. Apparently, 
however, the mutant protein bound to filaments of the vi- 
mentin type with preference over those of the cytokeratin 
type. The ability of plectin repeat 5 protein to associate 
with cytokeratin filaments was not restricted to cells de- 
rived from simple epithelia, such as PtK2, but applied also 
to epidermal, mostly vimentin-free keratinocytes, such as 
mouse Pare 212 cells (Fig. 8 C) and human A431 cells (not 
shown). 
Discussion 
Our initial study on plectin-IF interactions using transient 
transfection of plectin mutant cDNAs into cultured cells 
(Wiche et al.,  1993) indicated that the COOH-terminal 
domain of plectin, which contains several repeats of ho- 
mologous structure, plays an important role in this associa- 
tion. Using a similar approach in conjunction with in vitro 
binding and electron microscopic assays involving plectin 
mutant polypeptides expressed in bacteria, we have now 
narrowed down the vimentin-binding site of plectin to a 
relatively short stretch of ~50 amino acid residues residing 
at the end of its COOH-terminal repeat 5 domain. In addi- 
tion, we show evidence that plectin,s repeat 5 domain con- 
tains also a binding site for cytokeratins. 
The six COOH-terminal repeat domains of plectin share 
a strongly conserved ~200 residue long central region that 
is constructed from tandem repeats of a 19-residue motif. 
The IF-binding domain characterized in this study resides 
right after the repeat 5 core region and comprises ,-~50 res- 
idues.  Overall,  this  region  shares  hardly  any  homology 
with the corresponding regions of the other five repeats 
constituting the COOH-terminal globular domain of plec- 
tin. (Note that the regions between the core domains of 
each repeat and the beginning of the next repeat down- 
stream including the COOH terminus vary in length be- 
tween 7 [repeat 4] and 109 [repeat 5] amino acid residues.) 
While the amino-terminal boundary of the IF-binding site 
could  be  defined  rather  precisely  (lys4262), using  both 
transfection and in vitro binding assays (Figs. 2 and 5), its 
carboxy-terminal extension was  less evident. A  deletion 
mutant  protein  (pBN85)  which  lacks  14 flanking amino 
acid  residues  downstream  of the  essential  NLS-like  se- 
quence  domain  displayed clearly a  negative  phenotype, 
while a carboxy-terminal truncated mutant protein (pBN18) 
which extends 36  amino acid residues beyond the NLS- 
like sequence domain produced a positive/negative pheno- 
type (Figs. 2 and 5), indicating that binding occurred but 
only to a limited extent. Since the phenotype of a similar 
mutant  (pBN17)  with  a  35  residue  longer  flanking  se- 
quence was unambiguously positive (data not shown), we 
conclude that a sequence starting at the amino terminus of 
the bipartite NLS domain and containing between 55 and 
90 downstream amino acid residues is required for optimal 
binding.  The flanking domain  upstream  of the  NLS  se- 
quence, on the other hand, seems dispensable, if not inhib- 
itory for binding, considering that an amino-terminal trun- 
cated mutant protein (pBN56) starting just with the first 
basic cluster of the NLS sequence domain showed higher 
binding activity than mutants containing upstream flank- 
ing sequences, including one corresponding to repeats 4 
and 5 combined (pBN16). 
In vitro mutagenesis of different structural elements of 
the NLS sequence domain within plectin's IF-binding site 
indicated that the arg-lys-arg-arg cluster at position 4277- 
4280 at the carboxy-terminal boundary of the NLS domain 
was  crucial for binding.  Unimpaired  function of the  IF- 
binding site seemed to require also one or more residues 
of the hydroxyamino acid cluster (thr427°-ser  4275) preceding 
this basic cluster, since its mutagenesis effected a substan- 
tial decrease in" binding.  Interestingly, neutralization of a 
more 5'  basic cluster (residues 4265-4269) had a  slightly 
positive rather than negative effect on binding. It remains 
to be shown whether constituents of these clusters serve as 
targets for secondary protein modifications, such as phos- 
phorylation or acetylation. 
It might be fortuitous that the same sequence motif that 
enables a protein to enter the nucleus serves as an essen- 
tial structural element of the plectin-IF network complex, 
a cytoskeletal junction thought to provide cells with me- 
chanical strength. On the other hand, the observation that 
plectin binds to IFs via a domain comprising an NLS se- 
quence motif may suggest that IFs, in particular those of 
the vimentin type, may serve as cytoplasmic docking sites 
for  proteins  containing  such  sequences.  Such  docking 
could be important during various cell cycle phases, partic- 
ularly M-phase, when nuclear proteins are no longer spa- 
tially restricted by a nuclear envelope. In this context it is 
of interest that plectin and vimentin structures, which co- 
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ate during M-phase in conjunction with plectin phosphory- 
lation by p34  cdc2 protein kinase  (Foisner et al.,  1996).  A 
possible scenario could thus involve the same site on vi- 
mentin molecules in plectin-vimentin network formation 
leading to mechanical strengthening of cells during inter- 
phase, and cytoplasmic docking of nuclear proteins during 
M-phase. In postmitotic cells, reestablished plectin-vimen- 
tin interactions could lead to the release of NLS-bearing 
proteins  and  their re-entry into  the  nucleus.  Consistent 
with this hypothesis, vimentin filaments have been shown 
during mitosis to serve as a transient docking site for inner 
nuclear membrane vesicles carrying on their surface pro- 
teins with  NLS sequences, such as lamin  B  and nuclear 
membrane protein p58 (Maison et al.,  1993).  Plectin may 
also play a role in cellular functions involving its direct in- 
teraction with  cytoplasmic NLS-binding proteins  of the 
nuclear transport carrier machinery, such as Srpl-like pro- 
teins (Adam, 1995).  The potential ability of plectin to in- 
teract with such proteins was indicated by efficient nuclear 
import of a plectin mutant protein (pBN85) having an in- 
tact NLS sequence, but lacking the remaining part of the 
vimentin-binding domain. However, any of the above pos- 
sibilities related to a potential role of plectin's NLS signal 
motif apart from IF binding, as well as to mechanisms me- 
diating nuclear import of plectin mutants, remain specula- 
tive and require further investigation. 
Sharing  extensive structural  homology, particularly in 
their  COOH-terminal  repeat  domains,  plectin,  desmo- 
plakin,  and  BPA-1,  are  considered to comprise  a  novel 
gene  family  involved in  IF  organization  (Wiche  et  al., 
1991; Green et al.,  1992; Liu et al.,  1996).  In fact, in des- 
moplakin,  but  not  BPA-1,  the  region  corresponding  to 
plectin's vimentin-binding domain, including its NLS se- 
quence  motif, is  highly conserved. The COOH-terminal 
globular domain of desmoplakin  comprises three repeat 
domains  (Green et  al.,  1990)  compared to  six found in 
plectin, with the highest degree of homology found in the 
last two domains of both molecules. Upon examination of 
the sequence alignment of plectin's repeat 5 and desmo- 
plakin's  repeat B  domains,  an equivalent NLS sequence 
motif was  found in  desmoplakin  at  positions  1328-1346. 
Human and rat plectin are 100% identical in this region 
(Liu et al., 1996).  Consistent with our analysis of plectin, 
based on truncation mutagenesis, Stappenbeck et al. (1993) 
suggested that the molecular domain of desmoplakin nec- 
essary for binding to vimentin resided within the COOH- 
terminal globular domain somewhere upstream of repeat 
C. Whether the region identified in plectin also serves as a 
vimentin-binding site in desmoplakin remains to be shown, 
especially as a  couple of nonconserved cysteine residues 
found in  these  regions  may alter the  conformation and 
function of the corresponding domains in both proteins. 
The appearances of IF networks reconstituted from in 
vitro assembled  vimentin filaments  and  plectin repeat 5 
domain were similar to those reported for filaments deco- 
rated with whole plectin molecules purified from glioma 
C6 cells (Foisner et al.,  1988). Intact plectin molecules in 
solution  resemble  dumbbell-shaped  rod  structures  that 
have a high tendency to aggregate via their globular end 
domains  flanking  the  rod  (Foisner  and  Wiche,  1987; 
Weitzer and Wiche, 1987).  Under the conditions we used 
for visualizing  IF  networks  in  the  electron microscope, 
both whole plectin molecules (Foisner at al., 1988) and re- 
combinant repeat 5 protein (this study) appear as globular 
filament-attached aggregates  of ill-defined structure  and 
size. In both cases one can assume that at least some of the 
highly hydrophilic IF-binding sites of plectin molecules are 
exposed on the surface of these aggregates leading to the 
bridging  of filaments  and  eventually to  their packaging 
into dense networks. This may also be the mechanism un- 
derlying the collapse of IF networks in cultured cells upon 
transfection  of cDNA  constructs  encoding  mutant  pro- 
teins containing plectin's IF-binding site. 
It may be argued that recombinant proteins expressed in 
bzacteria might possess different properties, including bind- 
ing specificities, compared to their counterparts expressed 
in mammalian cells. This seemed to pose little problem, 
however, in this study because in general the results ob- 
tained by transfection of plectin mutant cDNA  into cul- 
tured  cells  were  fully consistent  with  those  based  on  in 
vitro binding assays using proteins expressed in bacteria. 
The quantitative  in  vitro assay we  applied in  this  study 
measures the binding of Eu3÷-labeled vimentin in solution 
to plectin proteins immobilized on plastic dishes. One of 
the advantages of this assay was that due to its high sensi- 
tivity the concentration of soluble vimentin could be kept 
low enough (nM range) to minimize distorting effects due 
to aggregation of the  IF protein. In fact, we observed a 
concentration-dependent binding of vimentin to immobi- 
lized plectin repeat 5 in the range of 1-500 nM, enabling 
the determination of a Ka =  90 nM, similar to that of puri- 
fied whole plectin, by Scatchard plot analysis. A  similar, 
more detailed study of the binding behavior of recombi- 
nant  plectin  mutant  proteins  corresponding to  different 
domains of the molecule and including other previously 
identified binding  partners  of plectin  is  currently being 
carried out (to be published elsewhere). 
Transient transfection of cDNAs into simple epithelia- 
derived PtK2 cells, which expressed both a vimentin and a 
cytokeratin IF  network,  and  into  the  epidermal  kerati- 
nocyte cell lines, Pam 212 and A431, which expressed only 
cytokeratins, indicated that repeat 5 contained a cytokera- 
tin-binding  site  in  addition  to  its  vimentin-binding  site. 
Since in PtK2 cells none of the mutant proteins deficient in 
binding  to  vimentin  showed  binding  to  the  cytokeratin 
network, it is  likely that plectin interacts with both fila- 
ment systems of this cell type via the same molecular do- 
main. However, association of the mutant protein with the 
cytokeratin network of PtK2 cells seemed to be less  fa- 
vored than that with vimentin, indicating differential bind- 
ing affinities of the repeat 5 domain for these networks. 
Whether this might apply also to cytokeratin filaments of 
different subunit composition, such as those from simple 
epithelia vs those from stratified epithelia, or basal vs su- 
prabasal  epidermal keratinocytes, remains an interesting 
question to be studied. Furthermore, the possibility that 
molecular domains other than, or in addition to, repeat 5 
are involved in plectin's interactions with various cytoker- 
atin IFs cannot be ruled out. In fact, preliminary in vitro 
binding data suggest that plectin has more than one bind- 
ing  site  for keratins  isolated  from  human  skin  (unpub- 
lished results). 
In  line  with  plectin's  proposed  role  as  a  cytoskeletal 
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strength, studies by Gache et al. (1996)  indicate that de- 
fects in plectin play a role in epidermolysis bullosa simplex 
(EBS)  with muscular  dystrophy,  an  autosomal  recessive 
skin blistering disease associated with a dystrophic muscle 
condition.  Moreover,  genetic  linkage  analysis  indicates 
that defects in plectin may also be involved in EBS-Ogna, 
a severe skin blistering disease associated with a dominant 
mutation  (Gedde-Dahl,  1990;  and  unpublished  observa- 
tions). It will be a challenging task for future research to 
investigate whether the mutations of the plectin gene in- 
volved  in these  and other diseases  affect  the IF-binding 
site of plectin characterized in this study. 
We thank Drs. HelmuI Denk and Peter Traub for providing antibodies, 
and Dr. Marion Schmidt-Zachmann for a PK plasmid. 
This work was supported by grant P9782 from the Austrian Science Re- 
search Fund. 
Received for publication 10 April 1996 and in revised form 2 July 1996. 
References 
Adam, S.A. 1995. The importance of importin. Trends Cell Biol. 5:189-191. 
BIose, SH., and D.L Meltzer. 1981. Visualization of the 10-nm filament vimen- 
tin rings in vascular endothelial cells in situ. Exp.  Cell Res. 135:299-309. 
Bradford, M.M. 1976. A  rapid and sensitive method for the quanfitation of mi- 
crogram quantities of protein utilizing the principle of protein-dye binding. 
Anal  Biochem. 72:248-254. 
Chelsky, D.,  R.  Ralph, and G. Jonak.  1989.  Sequence requirements for syn- 
thetic peptide-mediated translocation to the nucleus. MoL Cell BioL 9:2487- 
2492. 
Denk, ll., W.W. Franke, B. Dragosics, and I. Zeiler. 1981. Pathology of cyto- 
skeleton of liver cells: demonstration of Mallory bodies (alcoholic hyalin) in 
murine and human hepatocytes by immunofluorescence microscopy using 
antibodies to cytokeratin polypeptides from hepatocytes. Hepatology.  l:9ff. 
Errante, L.D., G. Wiche, and G. Shaw. 1994. The distribution of plectin, an in- 
termediate filament associated protein, in the adult rat central nervous sys- 
tem. J. Neurosci. Res. 37:515-528. 
Foisner,  R.,  and G.  Wiche.  1987.  Structure and hydrodynamic properties of 
plectin molecules. Z MoL BioL 198:515-531. 
Foisner,  R.,  F.E.  Leichtfried, H.  Herrmann,  J,V.  Small, D.  Lawson, and G. 
Wiche. 1988. Cytoskeleton-associated plectin: in situ localization, in vitro re- 
constitution, and binding to immobilized intermediate filament proteins..L 
Cell Biol. 106:723-733. 
Foisner, R., P. Traub, and G. Wiche. 1991. Protein kinase A- and protein kinase 
C-regulated interaction of plectin with lamin B  and vimentin. Proc,  Natl. 
Acad. Sci  USA. 88:3812-3816. 
Foisner, R., N. Malecz, N. Dressel, C. Stadler, and G. Wiche. 1996.  M-phase 
specific phosphorylation and structural rearrangement of the cytoplasmic 
cross-linking protein  plectin involve p34cdc2 kinase. MoL  BioL  CelL  7: 
273-288. 
Gache, Y., S.,  Chavanas, J.P.  Lacour, G. Wiche, K. Owaribe, G. Meneguzzi, 
and J.P.  Ortonne.  1996.  Defective expression of plectin in Epidermolysis 
Bullosa Simplex with muscular dystrophy. ,L Clin. Invest. 97:2289-2298. 
Gedde-Dahl, Jr., T.  1990. Epidermolysis bullosa simplex (intraepidermal epi- 
dermolysis bullosa) and  allied conditions.  Management of  blistering dis- 
eases. F.  Wojnarowska and R.A. Briggaman, editors. Chapman and Hall 
Medical London, UK. pp. 189-211. 
Giese, G., and P. Traub.  1986.  Induction of vimentin synthesis in mouse my- 
eloma ceils MPC-11  by 12-0-tetradecanoylphorbol-13-acetate. Ear.  J.  Cell 
BioL 40:266-274. 
Graham, F.L., and E. van der Eb. 1973. A new technique for the assay of infec- 
tivity of human adenovirus 5 DNA. Virology. 52:456-467. 
Green, K.J.,  D.A.D. Parry, P.M. Steinert, M.L.A. Virata, R.M. Wagner, B.D. 
Angst, and L.A. Nilles. 1990. Structure of human desmoplakins: implications 
for function in the desmosomal plaque. J. BioL Chem. 265:2603-2612. 
Green, K.J., M.L.A. Virata, G.W. Elgart, J.R. Stanley, and D.A.D. Parry. 1992. 
A comparative structural analysis of desmoplakin, bullous pemphigoid anti- 
gen and plectin: members of a new gene family involved in organization of 
intermediate filaments, lnt~ J. Biol. Macromol. 24:145-153. 
Herrmann, H., and G. Wiche. 1987.  Plectin and IFAP-300K are homologous 
proteins binding to microtubule-associated proteins 1 and 2 and to the 240- 
kilodalton subunit of spectrin. Z  BioL Chem. 262:1320-1325. 
Herrmann, H., and G. Wiche. 1983. Specific in situ phosphorylation of plectin in 
detergent-resistant cytoskeletons from cultured chinese hamster ovary ceils. 
Z  BioL Chem. 258:14610-14618. 
Horton,  R.M.,  ll.D. Hunt, S.N.  llo, J.K.  Pullen, and L.R.  Pease.  1989. Engi- 
neering hybrid genes without the use of restriction enzymes: gene splicing  by 
overlap extension. Gene (Amst.). 77:61~o8. 
Liu, C.-g.,  C. Maercker, M.J.  Castafi6n, R. Hauptmann,  and G. Wiche. 1996. 
Human plecfin: organization of the gene, sequence analysis, and chromo- 
some localization (8q24). Proc. NatL Acad. Sci.  USA. 93:4278-4283. 
Maison, C., H. Horstmann, and S.D, Georgatos. 1993. Regulated docking of nu- 
clear membrane vesicles to vimentin filaments during mitosis. J.  Cell BioL 
123:1491-1505. 
Malecz, N., R. Foisner, C. Stadler, and G. Wiche. 1996. Identification of plectin 
as a p34  cdc2 kinase substrate and mapping of a single phosphorylation site. J. 
BioL Chem. 271:8203-8208. 
Robbins, L, S.M.  Dilworth, R.A. Laskey, and C. Dingwall. 1991. Two interde- 
pendent basic domains in nucleoplasmin nuclear targeting sequence: identi- 
fication of a class of bipartite nuclear targeting sequence. Cell. 64:615Mi23. 
Saiki, R.K., D.H. Gelfand, S. Stoffel, S.J.  Scharf, R. Higuchi, G.T. Horn, K.B. 
Mullis, and  A.  Erlich.  1988.  Primer-directed  enzymatic  amplification of 
DNA with a thermostable DNA polymerase. Science (Wash. DC). 239:487-491. 
Sawamura, D., K. Li, M.-L. Chou, and J. Uitto. 1991. Human bullous pemphi- 
gold antigen (BPAG1). Z  BioL Chem. 266:17784-17790. 
Seifert, G., D. Lawson, and G. Wiche. 1992. lmmunolocalization of the inter- 
mediate filament-associated protein plectin at focal contacts and actin stress 
fibers. Eur J. Cell Biol. 59:138-147. 
Soini,  E.,  and  T.  LOvgren.  1987.  Time-resolved  fluorescence  of  lanthanide 
probes and applications in biotechnology. CRC Crit.  Rev. Anal.  Chem.  18: 
105-154. 
Stappenbeck, T.S, E.A. Bornslaeger, C.M.  Corcoran, H.H.  Luu, M.L.A.  Vi- 
rata, and K.J.  Green.  1993.  Functional analysis of desmoplakin domains: 
specification of the interaction with keratin versus vimenfin intermediate fil- 
ament networks. J. Cell Biol. 123:691-705. 
Tyler, J.M.,  and D.  Branton.  1980.  Rotary shadowing of extended molecules 
dried from glycerol. J'. Ultrastruct.  Res. 71:95-102. 
Weitzer, G., and G. Wiche. 1987. Plecfin from bovine lenses: chemical proper- 
ties, structural analysis and initial identification of interaction partners. Eur. 
Z  Biochem.  169:41-52. 
Wiche~ G., H. Herrmann, F. Leichtfried, and R. Pytela. 1982. Plecfin: a  high- 
molecular-weight cytoskeletal polypeptide component that copurifies with 
intermediate filaments of  the  vimentin type.  Cold  Spring  Harbor  Symp. 
Quant. BioL 46:475482. 
Wiche, G., R. Krepler, U. Artlieb, R. Pytela, and H. Denk. 1983. Occurrence 
and immunolocalization of plectin in tissues. J. Cell BioL 97:887-901. 
Wiche, G., R. Krepler, U. Artlieb, R. Pytela, and W. Aberer. 1984. Identifica- 
tion of pteetin in different human cell types and immunolocalization at epi- 
thelial basal cell surface membranes. Exp. Cell Res. 155:43-49. 
Wiche, G,, B. Becket, K. Luber, G. Weitzer, M. J. Castafi6n, R. Hauptmann, C. 
Stratowa, and M. Stewart. 1991. Cloning and sequencing of rat plectin indi- 
cates a 466-kD polypeptide chain with a three-domain structure based on a 
central a-helical coiled coil. J. Cell BioL 114:83-99. 
Wiche, G., D. Gromov, A. Donovan, M. J. Castafi6n, and E. Fuchs. 1993. Ex- 
pression of plectin mutant cDNA in cultured cells indicates a role of C-ter- 
minal domain in intermediate filament association. Z  Cell BioL 121:607~19. 
Yaoita, E., G. Wiche, T. Yamamoto, K. Kawasaki, and I. Kihara. 1996. Perinu- 
clear distribution of plectin characterizes visceral epithelial cells of rat glom- 
eruli. Am. J. PathoL 149:319-328. 
Yuspa, S. H., P. Hawley-Nelson, B. Koehler, and J.R. Stanley. 1980. A survey of 
transformation markers in differentiating epidermal cell lines in culture. 
Cancer Res. 40:4694-4703. 
Zernig, G., and G. Wiche. 1985. Morphological integrity of single adult cardiac 
myocytes isolated by collangenase treatment: immunolocalization of tubulin, 
microtubule-associated proteins 1 and 2, plectin, vimentin, and vinculin. Eur. 
J. Cell BioL 38:113-I22. 
Nikolic et al. Ana(vsis of Plectin-Vimentin Binding Site  1467 